Implementation of a Diabetic Foot Prevention Strategy in Primary Care (iMplanta Study)
iMplanta
1 other identifier
interventional
1,520
1 country
1
Brief Summary
The goal of this two-arm cluster randomised controlled trial (RCT) is to evaluate the effectiveness of a new implementation strategy based on the ImM model for the Protocol of assistance to the person with diabetic foot (PAPDF) of the Balearic Islands Health Service in reducing complications of diabetic foot, compared to the current implementation strategy, in the primary care centers of Majorca. As secondary objectives we aim 1. To determine the reach of the implementation strategy in the GAPM primary care centers, 2.To compare the effectiveness of the PAPDF versus usual care in preventing diabetic foot complications, 3. To identify the number of healthcare professionals adhering to the implementation strategy and 4. To assess the sustainability of the implementation strategy over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2026
ExpectedJune 29, 2025
December 1, 2024
4 months
May 26, 2025
June 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reach
Percentage of patients with diabetes mellitus over 18 years of age who have the "Diabetic Foot Protocol" open in the electronic medical record divided by the total number of patients with DM over 18 years of age in the health centers of both groups.
At baseline, 6 months and 12 months.
Secondary Outcomes (4)
Effectiveness
At baseline, 6 months and 12 months.
Adoption
At baseline, 6 months and 12 months.
Implementation fidelity
At baseline, 6 months and 12 months.
Maintenance
At baseline, 6 months and 12 months.
Study Arms (2)
Implementation Mapping strategy
EXPERIMENTALPrimary care centers, participants and caregivers assigned to this group will be part of an intervention designed to adopt an implementation strategy that will enhance the effective integration of the Diabetic Foot Care Protocol by reducing the complications associated with diabetic foot.
Current implementation strategy for diabetic foot prevention
SHAM COMPARATORPrimary care centers, along with the participants and caregivers assigned to this group, will be integrated into routine care to prevent complications associated with diabetic foot.
Interventions
The intervention will be based on the Implementation Mapping methodology (IM). This model is based on the Intervention Mapping. IM consists of several specific tasks: 1. Conduct an assessment of needs and identification of programme adopters and implementers through a review of qualitative or mixed studies assessing the perceptions of both patients and professionals regarding DF prevention as well as individual semi-structured interviews with patients, health professionals and management staff 2. Indicate adoption and implementation outcomes and action objectives, identifying determinants and create matrices of change; this process will allow for the identification of determinants, which are those factors that influence the actions will be implemented 3. Select theoretical methods and select or design implementation strategies using the ERIC model (Expert Recommendations for Implementing Change) 4. Produce implementation protocols and materials 5. Evaluate implementation results
Usual care: No systematic implementation of the protocol based on the prevention of foot at risk, ulcer treatment and screening of the risk of diabetic foot ulcer for referral to hospital care.
Eligibility Criteria
You may qualify if:
- Diagnosis of type 1 or type 2 diabetes mellitus.
- Aged 18 years or older.
- Attending nursing consultations at participating primary care centers during the study period.
You may not qualify if:
- Patients with gestational diabetes.
- Patients with diabetic foot ulcers prior to the start of the study.
- Patients with lower limb amputations prior to the start of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gerència d'Atenció Primària de Mallorca, Palma De Mallorca, Balearic Islands 07002
Palma de Mallorca, Balearic Islands, 07120, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2025
First Posted
June 4, 2025
Study Start
September 1, 2025
Primary Completion
December 22, 2025
Study Completion (Estimated)
December 22, 2026
Last Updated
June 29, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share